Back to results
US 2006/0069130 A1Published application
Novel crystals
AssigneeYamanouchi Pharmaceutical Co., Ltd.
InventorsHirokazu Kubota, Kiyoshi Iwaoka, Sou Yamaguchi, Masaki Yokota
Life of this patent
Estimating the term…
Abstract
Obtaining the crystal of 4,6-dimethyl-4′-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]nicotinanilide having excellent activity of inhibiting Ca2+ release-activated Ca2+ channel and suppressing IL-2 production to find that the compound includes the presence of two types of polymorphic crystals and that any of the crystals is preferable as a raw material for producing pharmaceutical compositions.
Claims7
A crystal of 4,6-dimethyl-4′-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]nicotinanilide.
Dependencies are inferred from the claim text.